Skip to main content
SpringerLink
Log in
Book cover

Chemoradiation in Cancer Therapy pp 253–269Cite as

Combined Modality Therapy for Gastric, Pancreatic, and Biliary Tract Carcinomas

  • Chapter

  • 123 Accesses

Part of the book series: Cancer Drug Discovery and Development ((CDD&D))

Abstract

Localized cancers are not often treated using a single modality. Rather, they are approached in a multidisciplinary manner. This approach has evolved over the past 15 yr to include medicine, surgery, radiation oncology, and gastroenterology.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Anonymous, SEER Cancer Statistics Review, 1973–98. 1998.

    Google Scholar 

  2. Neugut AI, Hayek M, Howe G. Epidemiology of gastric cancer. Semin Oncol 1996; 23 (3): 281–291.

    PubMed  CAS  Google Scholar 

  3. Gonzalez CA, et al. Occupation and gastric cancer in Spain. Scand J Work Environ Health 1991; 17 (4): 240–247.

    Article  PubMed  CAS  Google Scholar 

  4. Kneller RW, et al. Occupational risk factors for gastric cancer in Shanghai, China. Am J Ind Med 1990; 18 (1): 69–78.

    PubMed  CAS  Google Scholar 

  5. Parent ME, Siemiatycki J, Fritschi L. Occupational exposures and gastric cancer. Epidemiology 1998; 9 (1): 48–55.

    Article  PubMed  CAS  Google Scholar 

  6. Tsuda T, et al. A case-control study of the relationships among silica exposure, gastric cancer, and esophageal cancer. Am J Ind Med 2001; 39 (1): 52–57.

    Article  PubMed  CAS  Google Scholar 

  7. Sugimura T, Matsukura N, Sato S. Intestinal metaplasia of the stomach as a precancerous stage. IARC Sci Publ 1982; 39: 515–530.

    PubMed  Google Scholar 

  8. Lei DN, Yu JY. Types of mucosal metaplasia in relation to the histogenesis of gastric carcinoma. Arch Pathol Lab Med 1984; 108 (3): 220–224.

    PubMed  CAS  Google Scholar 

  9. Brennan MF, Karpeh MS Jr. Surgery for gastric cancer: the American view. Semin Oncol 1996; 23 (3): 352–359.

    PubMed  CAS  Google Scholar 

  10. Bonenkamp JJ, et al. Extended lymph-node dissection for gastric cancer. Dutch Gastric Cancer Group. N Engl J Med 1999; 340 (12): 908–914.

    Article  PubMed  CAS  Google Scholar 

  11. Cuschieri A, et al. E.A.E.S. multicenter prospective randomized trial comparing two-stage vs single-stage management of patients with gallstone disease and ductal calculi. Surg Endosc 1999; 13 (10): 952–957.

    Article  PubMed  CAS  Google Scholar 

  12. Cuschieri A, et al. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. Br Cancer 1999; 79 (9–10): 1522–1530.

    Article  CAS  Google Scholar 

  13. Safran H, et al. Paclitaxel and concurrent radiation therapy for locally advanced adenocarcinomas of the pancreas, stomach, and gastroesophageal junction. Seminars in Radiation Oncology 1999; 9 (2 Suppl 1): 53–57.

    PubMed  CAS  Google Scholar 

  14. Hermans J, et al. Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials. J Clin Oncol 1993; 11 (8): 1441–1447.

    PubMed  CAS  Google Scholar 

  15. Earle CC, Maroun A. Adjuvant chemotherapy after curative resection for gastric cancer: Revisiting a meta-analysis of randomized trials (abstract). Proc Am Soc Clin Oncol 1998.

    Google Scholar 

  16. Macdonald JS, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 2001; 345 (10): 725–730.

    Article  PubMed  CAS  Google Scholar 

  17. Gold EB, Goldin SB. Epidemiology of and risk factors for pancreatic cancer. Surg Oncol Clin NAm 1998; 7 (1): 67–91.

    CAS  Google Scholar 

  18. Landis SH, et al. Cancer statistics, 1998. (erratum appears in CA Cancer J Clin 1998 May-Jun;48(3):192; CA Cancer J Clin 1998 Nov-Dec;48(6):329). Ca: a Cancer Journal for Clinicians, 1998; 48 (1): 6–29.

    CAS  Google Scholar 

  19. Wingo PA, et al. Annual report to the nation on the status of cancer, 1973–1996, with a special section on lung cancer and tobacco smoking. J Natl Cancer Inst 1999; 91 (8): 675–690.

    Article  PubMed  CAS  Google Scholar 

  20. La Vecchia C, et al. Smoking and cancer with emphasis on Europe. Eur J Cancer 1991; 27 (1): 94–104.

    Article  PubMed  Google Scholar 

  21. Mack TM, et al. Pancreas cancer and smoking, beverage consumption, and past medical history. J Natl Cancer Inst 1986; 76 (1): 49–60.

    PubMed  CAS  Google Scholar 

  22. Olsen GW, et al. A case-control study of pancreatic cancer and cigarettes, alcohol, coffee and diet. Am J Public Health 1989; 79 (8): 1016–1019.

    Article  PubMed  CAS  Google Scholar 

  23. Silverman DT, et al. Cigarette smoking and pancreas cancer: a case-control study based on direct interviews. J Natl Cancer Inst 1994; 86 (20): 1510–1516.

    Article  PubMed  CAS  Google Scholar 

  24. Zheng W, et al. A cohort study of smoking, alcohol consumption, and dietary factors for pancreatic cancer (United States). Cancer Causes Control 1993; 4 (5): 477–482.

    Article  PubMed  CAS  Google Scholar 

  25. Mancuso TF, el-Attar AA. Cohort study of workers exposed to betanaphthylamine and benzidine. J Occup Med 1967; 9 (6): 277–285.

    PubMed  CAS  Google Scholar 

  26. Pietri F, Clavel F. Occupational exposure and cancer of the pancreas: a review. Br J Ind Med 1991; 48 (9): 583–587.

    PubMed  CAS  Google Scholar 

  27. Hruban RH, et al. Genetics of pancreatic cancer. From genes to families. Surg Oncol Clin NAm 1998; 7 (1): 1–23.

    CAS  Google Scholar 

  28. Nomoto S, et al. Clinical application of K-ras oncogene mutations in pancreatic carcinoma: detection of micrometastases. Semin Surg Oncol 1998; 15 (1): 40–46.

    Article  PubMed  CAS  Google Scholar 

  29. Wilentz RE, Hruban RH. Pathology of cancer of the pancreas. Surg Oncol Clin N Am 1998; 7 (1): 43–65.

    PubMed  CAS  Google Scholar 

  30. Wingo PA, et al. Cancer incidence and mortality, 1973–1995: a report card for the U.S. Cancer, 1998; 82 (6): 1197–1207.

    Article  PubMed  CAS  Google Scholar 

  31. Kelsen DP, et al. Pain and depression in patients with newly diagnosed pancreas cancer. J Clin Oncol 1995; 13 (3): 748–755.

    PubMed  CAS  Google Scholar 

  32. Krech RL, Walsh D. Symptoms of pancreatic cancer. J Pain Symptom Manage 1991; 6 (6): 360–367.

    Article  PubMed  CAS  Google Scholar 

  33. Passik SD, Breitbart WS. Depression in patients with pancreatic carcinoma. Diagnostic and treatment issues. Cancer 1996; 78 (3 Suppl): 615–626.

    PubMed  CAS  Google Scholar 

  34. Lillemoe KD, Pitt HA. Palliation. Surgical and otherwise. Cancer 1996; 78 (3 Suppl): 605–614.

    Article  PubMed  CAS  Google Scholar 

  35. Bluemke DA, Fishman EK. CT and MR evaluation of pancreatic cancer. Surg Oncol Clin N Am 1998; 7 (1): 103–124.

    PubMed  CAS  Google Scholar 

  36. Fuhrman GM, et al. Thin-section contrast-enhanced computed tomography accurately predicts the resectability of malignant pancreatic neoplasms. Am J Surg 1994; 167(1):104–111; discussion 111–113.

    Article  Google Scholar 

  37. Stevens PD, Lightdale CJ. The role of endosonography in the diagnosis and management of pancreatic cancer. Surg Oncol Clin N Am 1998; 7 (1): 125–133.

    PubMed  CAS  Google Scholar 

  38. Fernandez-del Castillo CL, Warshaw AL. Pancreatic cancer. Laparoscopic staging and peritoneal cytology. Surg Oncol Clin N Am 1998; 7 (1): 135–142.

    PubMed  CAS  Google Scholar 

  39. Steinberg WM, et al. Workup of a patient with a mass in the head of the pancreas. Pancreas 1998; 17 (1): 24–30.

    Article  PubMed  CAS  Google Scholar 

  40. Posner MR, Mayer RJ. The use of serologic tumor markers in gastrointestinal malignancies. Hematol Oncol Clin North Am 1994; 8 (3): 533–553.

    PubMed  CAS  Google Scholar 

  41. Nakao A, et al. Clinical usefulness of CA-19–9 in pancreatic carcinoma. Semin Surg Oncol 1998; 15 (1): 15–22.

    Article  PubMed  CAS  Google Scholar 

  42. Ritts RE, Pitt HA. CA 19–9 in pancreatic cancer. Surg Oncol Clin NAm 1998; 7 (1): 93–101.

    CAS  Google Scholar 

  43. Evans DB, Jessup JM, Colacchio T. Pancreatic cancer surgical practice guidelines. Pancreatic Cancer Practice Guideline Committee. Oncology (Huntingt) 1997; 11 (7): 1074–1079.

    CAS  Google Scholar 

  44. Nitecki SS, et al. Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving? Ann Surg 1995; 221 (1): 59–66.

    Article  PubMed  CAS  Google Scholar 

  45. GITSG, A multi-institutional comparative trial of radiation therapy alone and in combination with 5-fluorouracil for locally unresectable pancreatic carcinoma. The Gastrointestinal Tumor Study Group. Ann Surg 1979; 189 (2): 205–208.

    Google Scholar 

  46. GITSG, Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Gastrointestinal Tumor Study Group. Cancer 1987; 59 (12): 2006–2010.

    Article  Google Scholar 

  47. Sohn TA, et al. Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg 2000; 4 (6): 567–579.

    Article  PubMed  CAS  Google Scholar 

  48. Kaiser MH, Ellenberg SS. Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 1985; 120 (8): 899–903.

    Article  Google Scholar 

  49. Klinkenbijl JH, et al. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group. Ann Surg 1999; 230(6):776–782; discussion 782–784.

    Google Scholar 

  50. Spitz FR, et al. Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas. J Clin Oncol 1997; 15 (3): 928–937.

    PubMed  CAS  Google Scholar 

  51. Willett CG, et al. Resection margins in carcinoma of the head of the pancreas. Implications for radiation therapy. Ann Surg 1993; 217 (2): 144–148.

    Article  PubMed  CAS  Google Scholar 

  52. Staley CA, et al. Preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for adenocarcinoma of the pancreatic head. Am J Surg 1996; 171(1):118–124; discussion 124–125.

    Article  Google Scholar 

  53. Griffin JF, et al. Patterns of failure after curative resection of pancreatic carcinoma. Cancer 1990; 66 (1): 56–61.

    Article  PubMed  CAS  Google Scholar 

  54. Breslin TM, et al. Neoadjuvant chemoradiation for adenocarcinoma of the pancreas. Frontiers Biosci 1998; 3: E193–203.

    CAS  Google Scholar 

  55. Hoffman JP, et al. Phase II trial of preoperative radiation therapy and chemotherapy for patients with localized, resectable adenocarcinoma of the pancreas: an Eastern Cooperative Oncology Group Study. J Clin Oncol 1998; 16 (1): 317–323.

    PubMed  CAS  Google Scholar 

  56. Pisters PW, et al. Preoperative chemoradiation for patients with pancreatic cancer: toxicity of endobiliary stents. J Clin Oncol 2000; 18 (4): 860–867.

    PubMed  CAS  Google Scholar 

  57. Hidalgo M, et al. Phase I-II study of gemcitabine and fluorouracil as a continuous infusion in patients with pancreatic cancer. J Clin Oncol 1999; 17 (2): 585–592.

    PubMed  CAS  Google Scholar 

  58. Lawrence TS, et al. Radiosensitization of pancreatic cancer cells by 2’,2’-difluoro-2’-deoxycytidine. Int J Radiat Oncol Biol Phys 1996; 34 (4): 867–872.

    Article  PubMed  CAS  Google Scholar 

  59. Miller AR, et al. Neoadjuvant chemoradiation for adenocarcinoma of the pancreas. Surg Oncol Clin N Am 1998; 7 (1): 183–197.

    PubMed  CAS  Google Scholar 

  60. Robertson JM, Shewach DS, Lawrence TS. Preclinical studies of chemotherapy and radiation therapy for pancreatic carcinoma. Cancer 1996; 78 (3 Suppl): 674–679.

    PubMed  CAS  Google Scholar 

  61. Yamaguchi K, Tsuneyoshi M. Subclinical gallbladder carcinoma. Am J Surg 1992; 163 (4): 382–386.

    Article  PubMed  CAS  Google Scholar 

  62. Oertli DU, Herzog, Tondelli P. Primary carcinoma of the gallbladder: operative experience during a 16 year period. Eur J Surg 1993; 159 (8): 415–420.

    PubMed  CAS  Google Scholar 

  63. Fong Y. Aggressive therapy is warranted for gallbladder cancer. Cancer Invest 1998; 16 (1): 64–65.

    Article  PubMed  CAS  Google Scholar 

  64. de Aretxabala XA, et al. Curative resection in potentially resectable tumours of the gallbladder. Eur J Surg 1997; 163 (6): 419–426.

    PubMed  Google Scholar 

  65. Shepherd HA, et al. Endoscopie biliary endoprosthesis in the palliation of malignant obstruction of the distal common bile duct: a randomized trial. Br J Surg 1988; 75 (12): 1166–1168.

    Article  PubMed  CAS  Google Scholar 

  66. Andersen JR, et al. Randomised trial of endoscopie endoprosthesis versus operative bypass in malignant obstructive jaundice. Gut 1989; 30 (8): 1132–1135.

    Article  PubMed  CAS  Google Scholar 

  67. Meyer CG, Penn I, James L. Liver transplantation for cholangiocarcinoma: results in 207 patients. Transplantation 2000; 69 (8): 1633–1637.

    Article  PubMed  CAS  Google Scholar 

  68. Strong RW. Transplantation for liver and biliary cancer. Semin Surg Oncol 2000; 19 (2): 189–199.

    Article  PubMed  CAS  Google Scholar 

  69. Wall WJ, Liver transplantation for hepatic and biliary malignancy. Semin Liver Dis 2000; 20 (4): 425–436.

    Article  PubMed  CAS  Google Scholar 

  70. Bartlett DL, et al. Long-term results after resection for gallbladder cancer. Implications for staging and management. Ann Surg 1996; 224 (5): 639–646.

    Article  PubMed  CAS  Google Scholar 

  71. Yamamoto M, et al. Recurrence after surgical resection of intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg 2001; 8 (2): 154–157.

    Article  PubMed  CAS  Google Scholar 

  72. de Aretxabala X, et al. Preoperative chemoradiotherapy in the treatment of gallbladder cancer. Am Surg 1999; 65 (3): 241–246.

    PubMed  Google Scholar 

  73. McMasters KM, et al. Neoadjuvant chemoradiation for extrahepatic cholangiocarcinoma. Am J Surg 1997; 174(6):605–608; discussion 608–609.

    Article  Google Scholar 

Download references

Authors
  1. Alexandria Phan MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jaffer A. Ajani MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Radiation Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, USA

    Hak Choy MD

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer Science+Business Media New York

About this chapter

Cite this chapter

Phan, A., Ajani, J.A. (2003). Combined Modality Therapy for Gastric, Pancreatic, and Biliary Tract Carcinomas. In: Choy, H. (eds) Chemoradiation in Cancer Therapy. Cancer Drug Discovery and Development. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-325-5_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-325-5_13

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-61737-313-8

  • Online ISBN: 978-1-59259-325-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation